Linking preclinical and clinical whole-body physiologically based pharmacokinetic models with prior distributions in NONMEM

By Langdon Grant   Gueorguieva Ivelina   Aarons Leon   Karlsson Mats  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 5, 2007-05 ,pp. : 485-498

Springer Publishing Company

Access to resources Recommend Favorite

Bayesian Analysis of a Physiologically Based Pharmacokinetic Model for Perchloroethylene in Humans

By Qiu Junshan   Chien Yeh-Chung   Bruckner James   Fisher Jeffery  

Journal of Toxicology and Environmental Health, Vol. 73, Iss. 1, 2010-01 ,pp. : 74-91

Taylor & Francis Ltd

Access to resources Recommend Favorite

Bayesian Calibration of a Physiologically Based Pharmacokinetic/Pharmacodynamic Model of Carbaryl Cholinesterase Inhibition

By Nong Andy   Tan Yu-Mei   Krolski Michael   Wang Jiansuo   Lunchick Curt   Conolly Rory   Clewell Harvey  

Journal of Toxicology and Environmental Health, Vol. 71, Iss. 20, 2008-01 ,pp. : 1363-1381

Taylor & Francis Ltd

Access to resources Recommend Favorite

Population-Based Analysis of Methadone Distribution and Metabolism Using an Age-Dependent Physiologically Based Pharmacokinetic Model

By Yang Feng   Tong Xianping   McCarver D.   Hines Ronald   Beard Daniel  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 33, Iss. 4, 2006-08 ,pp. : 485-518

Springer Publishing Company

Access to resources Recommend Favorite

Reducing Whole Body Physiologically Based Pharmacokinetic Models Using Global Sensitivity Analysis: Diazepam Case Study

By Gueorguieva Ivelina   Nestorov Ivan   Rowland Malcolm  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 33, Iss. 1, 2006-02 ,pp. : 1-27

Springer Publishing Company

Access to resources Recommend Favorite